GLAXOSMITHKLINE (IRELAND) LIMITED
- B01 - Agentes antitrombóticos
- FLOLAN powder and solvent for solution for injection 0.5 mg+50 ml
- FLOLAN powder and solvent for solution for injection 1.5 mg
- FLOLAN powder for solution for infusion 0.5 mg
- INTEGRILIN solution for infusion 75 mg/100 ml
- INTEGRILIN solution for injection 20 mg/10 ml
- C02 - Antihipertensivos
- VOLIBRIS film-coated tablet 10 mg
- VOLIBRIS film-coated tablet 2.5 mg
- VOLIBRIS film-coated tablet 5 mg
- J05 - Antivirales de uso sistémico
- ZEFFIX film-coated tablet 100 mg
- ZEFFIX oral solution 5 mg/ml
- L01 - Antineoplásicos
- BLENREP powder and solvent for solution for infusion 100 mg
- JEMPERLI solution for infusion 500 mg
- ZEJULA capsule, hard 100 mg
- L04 - Inmunosupresores
- BENLYSTA powder for solution for infusion 120 mg
- BENLYSTA powder for solution for infusion 400 mg
- BENLYSTA PREFILLED PEN solution for injection 200 mg/1 ml
- BENLYSTA PREFILLED SYRINGE solution for injection 200 mg/1 ml
- P01 - Antiprotozoarios
- WELLVONE oral suspension 240 ml
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- ANORO ELLIPTA inhalation powder 22 µg/dose+55 µg/dose
- INCRUSE ELLIPTA inhalation powder 55 µg/dose
- RELVAR ELLIPTA inhalation powder 22 µg/dose+184 µg/dose
- RELVAR ELLIPTA inhalation powder 22 µg/dose+92 µg/dose
- REVINTY ELLIPTA inhalation powder, pre-dispensed 184 µg+22 µg
- REVINTY ELLIPTA inhalation powder, pre-dispensed 92 µg+22 µg